Henan Taloph Pharmaceutical Stock Co.,Ltd (SHA:600222)

SHA:600222 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	243.63	180.04	196.67	311.38	380.55	487.32
Trading Asset Securities	2.2	80.02	153.3	74.96	285.67	207.46
Cash & Short-Term Investments	245.83	260.05	349.97	386.34	666.22	694.78
Cash Growth	-29.68%	-25.69%	-9.41%	-42.01%	-4.11%	20.92%
Accounts Receivable	1,143	1,137	1,056	1,038	744.71	689.25
Other Receivables	35.32	36.38	44.01	51.15	56.44	78.65
Receivables	1,178	1,173	1,100	1,089	801.15	767.89
Inventory	476.08	367.67	455.5	450.49	381.85	348.14
Other Current Assets	110.6	105.35	87.88	105.03	94.49	71.56
Total Current Assets	2,011	1,906	1,993	2,031	1,944	1,882
Property, Plant & Equipment	493.93	501.82	529.65	551.13	539.58	494.09
Long-Term Investments	521.95	526.67	520.38	490.93	825.63	533.76
Goodwill	286.49	286.49	286.49	286.49	286.49	286.49
Other Intangible Assets	48.57	51.17	52.5	48.11	53.1	57.54
Long-Term Deferred Tax Assets	115.59	113.2	94.24	95.38	52.4	47.16
Long-Term Deferred Charges	51.96	52.8	49.81	54.23	35.81	32.98
Other Long-Term Assets	49.78	51.55	50.71	49.08	47.05	54.99
Total Assets	3,579	3,490	3,577	3,607	3,784	3,389
Accounts Payable	275.58	294.89	470.29	548.89	355.65	211.71
Accrued Expenses	21.33	28.26	24.27	32.22	22.45	20.56
Short-Term Debt	712.49	663.42	381.84	404.87	973.58	750.22
Current Portion of Long-Term Debt	47.74	270.07	89.76	4.22	158.74	406.21
Current Portion of Leases	73.12	46.29	35.35	26.89	-	-
Current Income Taxes Payable	2.46	1.28	2.53	21.86	3.7	2.98
Current Unearned Revenue	3.74	6.54	11.62	88.26	49.47	61.27
Other Current Liabilities	418.59	483.76	634.5	598.82	86.09	50.94
Total Current Liabilities	1,555	1,795	1,650	1,726	1,650	1,504
Long-Term Debt	325.07	3.02	183.8	192.8	20.37	136.38
Long-Term Leases	18.97	42.04	89.29	37.14	72.06	31.6
Long-Term Unearned Revenue	2.61	2.78	3.26	1.71	-	-
Long-Term Deferred Tax Liabilities	22.22	21.16	25.36	33.26	132.42	56.96
Other Long-Term Liabilities	-	-	1.62	1.62	131.62	130
Total Liabilities	1,924	1,864	1,953	1,993	2,006	1,859
Common Stock	573.89	573.89	573.89	573.89	573.89	573.89
Additional Paid-In Capital	675.17	675.17	675.17	675.17	588.14	588.14
Retained Earnings	354.73	316.01	281.01	237.46	232.15	235.16
Treasury Stock	-109.8	-101.01	-79.72	-37.66	-48.7	-98.47
Comprehensive Income & Other	106.36	110.67	128.15	121.56	315.04	154.7
Total Common Equity	1,600	1,575	1,578	1,570	1,661	1,453
Minority Interest	54.77	51.51	44.89	43.62	117.13	77.16
Shareholders' Equity	1,655	1,626	1,623	1,614	1,778	1,531
Total Liabilities & Equity	3,579	3,490	3,577	3,607	3,784	3,389
Total Debt	1,177	1,025	780.03	665.92	1,225	1,324
Net Cash (Debt)	-931.55	-764.79	-430.07	-279.58	-558.53	-629.62
Net Cash Per Share	-1.68	-1.37	-0.76	-0.50	-1.00	-1.15
Filing Date Shares Outstanding	552.92	554.67	559.36	566.69	563.04	545.98
Total Common Shares Outstanding	552.92	554.67	559.36	566.69	563.04	545.98
Working Capital	455.72	111.55	342.93	305.21	294.03	378.49
Book Value Per Share	2.89	2.84	2.82	2.77	2.95	2.66
Tangible Book Value	1,265	1,237	1,239	1,236	1,321	1,109
Tangible Book Value Per Share	2.29	2.23	2.22	2.18	2.35	2.03
Buildings	556.93	556.93	543.26	534.9	520.76	516.81
Machinery	364.33	361.45	341.92	316.19	281.14	247.95
Construction In Progress	28.58	29.2	28.9	31.1	33.02	24.31

Source: S&P Global Market Intelligence. Standard template. Financial Sources.